Page 2 - Dr Reddys
Stocks to watch: TCS, M&M, Vedanta, Tata Power, Dr Reddy's, Tata Motors
Stocks to watch today: IT behemoth Tata Consultancy Services (TCS) is slated to report June quarter 2022 numbers (Q1FY23); Dr Reddy's received two observations from USFDA for its Andhra plant
 "Stocks to watch: TCS, M&M, Vedanta, Tata Power, Dr Reddy's, Tata Motors")
Sensex adds 428 pts, Nifty ends near 16,150; PSBs, OMCs rally; RIL down 1%
CLOSING BELL: It was, largely, a broad-based rally where the Nifty PSU Bank index advanced the most, up 3.4 per cent
 "Sensex adds 428 pts, Nifty ends near 16,150; PSBs, OMCs rally; RIL down 1%")
Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
Dr Reddy's Laboratories on Thursday said it has settled patent litigation with Indivior Inc and Aquestive Therapeutics on a medication used to treat opioid dependence or addiction
 "Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics")
Dr Reddy's acquire Eton Pharma's injectable products for $50 million
Under the terms of the agreement, Dr Reddy's acquired the Eton portfolio for an upfront payment of approximately USD 5 million in cash, besides contingent payments of up to USD 45 million
Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
Dr Reddy's Laboratories on Thursday said its subsidiary has inked a pact with US-based Olema Pharmaceuticals Inc to research, develop and commercialise novel small molecule inhibitors of a target
 "Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals")
Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%
The stock gained 9 per cent in two days after the pharma company reported better-than-expected revenue growth in March quarter (Q4FY22).
 "Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%")
Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
Dr Reddy's Laboratories is hoping to go to a regulator for its single-dose Sputnik Light jab as booster dose for approvals by June-end or early July, a senior official said
 "Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose")
75% of Nifty50 stocks trade below 200-DMA; look weak on the charts
Tech Mahindra and Wipro have tumbled over 30 per cent, while Apollo Hospitals Enterprise and Dr. Reddy's Laboratories have plummeted 22 per cent so far in calendar year 2022 (CY22)
 "75% of Nifty50 stocks trade below 200-DMA; look weak on the charts")
Dr. Reddy's plans 'business continuity' in Russia despite Western pullout
Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia
 "Dr. Reddy's plans 'business continuity' in Russia despite Western pullout")
Fag-end selling drags Sensex for 6th day, dips 69 pts; RIL slips 1%
Closing Bell: The frontline S&P BSE Sensex fell 69 points to settle at 57,232 levels while the Nifty50 shut shop at 17,063 down 29 points
 "Fag-end selling drags Sensex for 6th day, dips 69 pts; RIL slips 1%")
Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's
Mankind Pharma to take over manufacturing, marketing and distribution of both products in India; entire integration and transition of the brands likely to be completed by March
 "Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's")
Sensex slides 773pts, Nifty ends below 17400 amid global pullback; IT bleed
All the sectoral indices settled in the negative territory today with technology and public sector banks being the worst hit. The IT and PSB indices dropped nearly 3% and 2%, respectively
 "Sensex slides 773pts, Nifty ends below 17400 amid global pullback; IT bleed")
Stocks to Watch: L&T, Vedanta, NTPC, MCX, Dr.Reddy's, CBI, AU SFB, Textiles
BPCL, DLF, Dwarikesh Sugar, Exide, GIC Housing, HDIL, HPCL, IOC, Jindal Saw, KEC Intl, KPIT Tech, Krsnaa Diagnostics, SCI, Sun Pharma, Suven Life, Tata Motors and UCO Bank in focus ahead of Q3 results
 "Stocks to Watch: L&T, Vedanta, NTPC, MCX, Dr.Reddy's, CBI, AU SFB, Textiles")
Pricing trend, launches, stability of growth boosters for Dr Reddy's
Near-term outlook and valuation are expected to support the stock price
Sensex falls 884 pts from day's high, ends 77 pts down; Nifty holds 17,100
For the week, the Sensex and the Nifty indices are down 3% each
 "Sensex falls 884 pts from day's high, ends 77 pts down; Nifty holds 17,100")
Dr Reddy's may underperform over concerns about launch of complex products
For rerating, it needs sustained growth in India, recovery in US
 "Dr Reddy's may underperform over concerns about launch of complex products")
Dr Reddy's launches drug in US to treat high blood pressure, heart failure
The tablet is the generic therapeutic equivalent of Diovan, approved by the US Food and Drug Administration
 "Dr Reddy's launches drug in US to treat high blood pressure, heart failure")
Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
Prestige BioPharma Ltd announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and commercialisation of Trastuzumab biosimilar
 "Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar")
Osho Krishan expects bullish bias in Balrampur Chini, Dr.Reddy's, Whirlpool
According to the technical analyst from Anand Rathi, most technical indicators are in favour of the bullish bias for these three stocks
 "Osho Krishan expects bullish bias in Balrampur Chini, Dr.Reddy's, Whirlpool")
Mandaviya holds meeting with Dr Reddy's Chairman on Sputnik V supply
Dr Reddy's is in a pact with RDIF to sell 250 million vials of Sputnik V in India.
 "Mandaviya holds meeting with Dr Reddy's Chairman on Sputnik V supply")
